Safety and Efficacy of HydroLenz for Vitrectomy-Induced Lens Opacities

NCT05592912 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Funding Limitations

Conditions

Pars Plana Vitrectomy

Interventions

DRUG: HydroLenz Injection
OTHER: No HydroLenz Injection

Sponsor

PromiSight, LLC